Literature DB >> 1672062

Rationale and efficacy of conservative therapy for gastroesophageal reflux disease.

L I Kitchin1, D O Castell.   

Abstract

Major recent advances in the diagnosis and understanding of gastroesophageal reflux disease have afforded the practicing clinician a number of therapeutic options to treat the increasingly recognized affected patient population. With highly effective acid-suppressive therapies available, simple life-style modifications, such as selective food and medicine avoidance, weight loss, smoking cessation, elevation of the head of the bed, and the judicious use of antacids and alginate, have been relegated to a minor, if any, role in the management of these patients. The validity of these recommendations, however, remains consistent with our current understanding of the pathogenesis of gastroesophageal reflux disease. Although few well-designed placebo-controlled trials have been conducted, a review of the medical literature indicates an appreciable efficacy of these interventions, which are founded on well-studied physiologic determinants of gastroesophageal reflux. Most patients with gastroesophageal reflux disease can be managed by reassurance and simple life-style adjustments alone. The therapy for those with chronic or relapsing disease should always include the adjunctive reinforcement of these simple, efficacious, and cost-effective measures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672062

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  Treatment of gastro-oesophageal reflux disease in adults.

Authors:  J P Galmiche; E Letessier; C Scarpignato
Journal:  BMJ       Date:  1998-06-06

3.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

4.  Quantitative assessment of visceral fat in morbidly obese patients by means of wide-bore MRI and its relation to lower esophageal sphincter pressure and signs of gastroesophageal reflux.

Authors:  Fabian Springer; Manuel Schwarz; Jürgen Machann; Andreas Fritsche; Claus D Claussen; Fritz Schick; Joachim H Schneider
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

Review 5.  Oesophageal mucosal diseases in the elderly.

Authors:  R Ouatu-Lascar; G Triadafilopoulos
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

Review 6.  Functional oesophageal epithelial defense against acid.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Kazunari Tominaga; Toshio Watanabe; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

7.  Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population.

Authors:  J Kotzan; W Wade; H H Yu
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

Review 8.  Is preoperative manometry in restrictive bariatric procedures necessary?

Authors:  Alexander Klaus; Helmut Weiss
Journal:  Obes Surg       Date:  2008-04-02       Impact factor: 4.129

9.  Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients.

Authors:  E Kuster; E Ros; V Toledo-Pimentel; A Pujol; J M Bordas; L Grande; C Pera
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  Impact of Weight Loss Surgery on Esophageal Physiology.

Authors:  Rishi D Naik; Yash A Choksi; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.